INFUSYSTEM HOLDINGS INC (INFU) Fundamental Analysis & Valuation

NYSEARCA:INFU • US45685K1025

Current stock price

9.6 USD
+0.51 (+5.61%)
At close:
9.6 USD
0 (0%)
After Hours:

This INFU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. INFU Profitability Analysis

1.1 Basic Checks

  • INFU had positive earnings in the past year.
  • INFU had a positive operating cash flow in the past year.
  • In the past 5 years INFU has always been profitable.
  • In the past 5 years INFU always reported a positive cash flow from operatings.
INFU Yearly Net Income VS EBIT VS OCF VS FCFINFU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

1.2 Ratios

  • The Return On Assets of INFU (6.59%) is better than 85.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.56%, INFU is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • INFU has a Return On Invested Capital of 11.72%. This is amongst the best in the industry. INFU outperforms 84.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INFU is in line with the industry average of 8.86%.
  • The last Return On Invested Capital (11.72%) for INFU is above the 3 year average (7.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.59%
ROE 11.56%
ROIC 11.72%
ROA(3y)3.23%
ROA(5y)2.23%
ROE(3y)5.77%
ROE(5y)4.06%
ROIC(3y)7.25%
ROIC(5y)5.18%
INFU Yearly ROA, ROE, ROICINFU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • The Profit Margin of INFU (4.62%) is better than 77.00% of its industry peers.
  • In the last couple of years the Profit Margin of INFU has declined.
  • The Operating Margin of INFU (8.31%) is better than 73.00% of its industry peers.
  • INFU's Operating Margin has declined in the last couple of years.
  • The Gross Margin of INFU (55.98%) is better than 79.00% of its industry peers.
  • In the last couple of years the Gross Margin of INFU has remained more or less at the same level.
Industry RankSector Rank
OM 8.31%
PM (TTM) 4.62%
GM 55.98%
OM growth 3Y76.76%
OM growth 5Y-1.72%
PM growth 3Y555.86%
PM growth 5Y-23.64%
GM growth 3Y-0.56%
GM growth 5Y-1.49%
INFU Yearly Profit, Operating, Gross MarginsINFU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INFU Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INFU is creating some value.
  • Compared to 1 year ago, INFU has less shares outstanding
  • Compared to 5 years ago, INFU has less shares outstanding
  • Compared to 1 year ago, INFU has an improved debt to assets ratio.
INFU Yearly Shares OutstandingINFU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
INFU Yearly Total Debt VS Total AssetsINFU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 3.86 indicates that INFU is not in any danger for bankruptcy at the moment.
  • INFU's Altman-Z score of 3.86 is fine compared to the rest of the industry. INFU outperforms 75.00% of its industry peers.
  • INFU has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.25, INFU belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • INFU has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • INFU has a Debt to Equity ratio of 0.34. This is in the better half of the industry: INFU outperforms 66.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.25
Altman-Z 3.86
ROIC/WACC1.37
WACC8.58%
INFU Yearly LT Debt VS Equity VS FCFINFU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • INFU has a Current Ratio of 1.80. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
  • INFU has a Current ratio of 1.80. This is in the better half of the industry: INFU outperforms 74.00% of its industry peers.
  • INFU has a Quick Ratio of 1.53. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.53, INFU is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.53
INFU Yearly Current Assets VS Current LiabilitesINFU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INFU Growth Analysis

3.1 Past

  • INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.00%, which is quite impressive.
  • Measured over the past years, INFU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.01% on average per year.
  • INFU shows a small growth in Revenue. In the last year, the Revenue has grown by 6.36%.
  • Measured over the past years, INFU shows a quite strong growth in Revenue. The Revenue has been growing by 8.05% on average per year.
EPS 1Y (TTM)220%
EPS 3Y632.25%
EPS 5Y-17.01%
EPS Q2Q%150%
Revenue 1Y (TTM)6.36%
Revenue growth 3Y9.28%
Revenue growth 5Y8.05%
Sales Q2Q%7.04%

3.2 Future

  • Based on estimates for the next years, INFU will show a very strong growth in Earnings Per Share. The EPS will grow by 26.87% on average per year.
  • INFU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.39% yearly.
EPS Next Y32.54%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.56%
Revenue Next 2Y4.05%
Revenue Next 3Y6.65%
Revenue Next 5Y7.39%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
INFU Yearly Revenue VS EstimatesINFU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
INFU Yearly EPS VS EstimatesINFU Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. INFU Valuation Analysis

4.1 Price/Earnings Ratio

  • INFU is valuated quite expensively with a Price/Earnings ratio of 30.00.
  • INFU's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.54. INFU is around the same levels.
  • Based on the Price/Forward Earnings ratio of 22.64, the valuation of INFU can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of INFU is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, INFU is valued at the same level.
Industry RankSector Rank
PE 30
Fwd PE 22.64
INFU Price Earnings VS Forward Price EarningsINFU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INFU indicates a somewhat cheap valuation: INFU is cheaper than 78.00% of the companies listed in the same industry.
  • 77.00% of the companies in the same industry are more expensive than INFU, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.35
EV/EBITDA 8.35
INFU Per share dataINFU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INFU may justify a higher PE ratio.
  • INFU's earnings are expected to grow with 26.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y26.87%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INFU Dividend Analysis

5.1 Amount

  • INFU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INFU Fundamentals: All Metrics, Ratios and Statistics

INFUSYSTEM HOLDINGS INC

NYSEARCA:INFU (3/23/2026, 8:04:00 PM)

After market: 9.6 0 (0%)

9.6

+0.51 (+5.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners81.22%
Inst Owner Change6.66%
Ins Owners4.83%
Ins Owner Change0.42%
Market Cap194.11M
Revenue(TTM)143.44M
Net Income(TTM)6.63M
Analysts83.64
Price Target14.48 (50.83%)
Short Float %0.59%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.11%
Min EPS beat(2)34.8%
Max EPS beat(2)35.41%
EPS beat(4)4
Avg EPS beat(4)93.13%
Min EPS beat(4)34.8%
Max EPS beat(4)226.8%
EPS beat(8)5
Avg EPS beat(8)-2.06%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-2.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.99%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)6
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)28.46%
EPS NQ rev (3m)28.46%
EPS NY rev (1m)1.12%
EPS NY rev (3m)1.12%
Revenue NQ rev (1m)-1.18%
Revenue NQ rev (3m)-1.18%
Revenue NY rev (1m)-2.28%
Revenue NY rev (3m)-3.01%
Valuation
Industry RankSector Rank
PE 30
Fwd PE 22.64
P/S 1.35
P/FCF 12.35
P/OCF 7.95
P/B 3.39
P/tB 4.15
EV/EBITDA 8.35
EPS(TTM)0.32
EY3.33%
EPS(NY)0.42
Fwd EY4.42%
FCF(TTM)0.78
FCFY8.1%
OCF(TTM)1.21
OCFY12.57%
SpS7.09
BVpS2.84
TBVpS2.31
PEG (NY)0.92
PEG (5Y)N/A
Graham Number4.52
Profitability
Industry RankSector Rank
ROA 6.59%
ROE 11.56%
ROCE 14.83%
ROIC 11.72%
ROICexc 12.2%
ROICexgc 14.14%
OM 8.31%
PM (TTM) 4.62%
GM 55.98%
FCFM 10.96%
ROA(3y)3.23%
ROA(5y)2.23%
ROE(3y)5.77%
ROE(5y)4.06%
ROIC(3y)7.25%
ROIC(5y)5.18%
ROICexc(3y)7.43%
ROICexc(5y)5.29%
ROICexgc(3y)8.54%
ROICexgc(5y)6.12%
ROCE(3y)9.18%
ROCE(5y)6.56%
ROICexgc growth 3Y98.79%
ROICexgc growth 5Y1.51%
ROICexc growth 3Y99.27%
ROICexc growth 5Y2.4%
OM growth 3Y76.76%
OM growth 5Y-1.72%
PM growth 3Y555.86%
PM growth 5Y-23.64%
GM growth 3Y-0.56%
GM growth 5Y-1.49%
F-Score8
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.25
Debt/EBITDA 0.78
Cap/Depr 65.34%
Cap/Sales 6.06%
Interest Coverage 9.59
Cash Conversion 96.8%
Profit Quality 237.24%
Current Ratio 1.8
Quick Ratio 1.53
Altman-Z 3.86
F-Score8
WACC8.58%
ROIC/WACC1.37
Cap/Depr(3y)98.96%
Cap/Depr(5y)104.73%
Cap/Sales(3y)9.37%
Cap/Sales(5y)11.62%
Profit Quality(3y)120.46%
Profit Quality(5y)2807.88%
High Growth Momentum
Growth
EPS 1Y (TTM)220%
EPS 3Y632.25%
EPS 5Y-17.01%
EPS Q2Q%150%
EPS Next Y32.54%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.36%
Revenue growth 3Y9.28%
Revenue growth 5Y8.05%
Sales Q2Q%7.04%
Revenue Next Year0.56%
Revenue Next 2Y4.05%
Revenue Next 3Y6.65%
Revenue Next 5Y7.39%
EBIT growth 1Y72.98%
EBIT growth 3Y93.16%
EBIT growth 5Y6.19%
EBIT Next Year201.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y498.71%
FCF growth 3Y86.06%
FCF growth 5Y36.11%
OCF growth 1Y19.3%
OCF growth 3Y11.69%
OCF growth 5Y3.78%

INFUSYSTEM HOLDINGS INC / INFU Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INFUSYSTEM HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to INFU.


What is the valuation status for INFU stock?

ChartMill assigns a valuation rating of 5 / 10 to INFUSYSTEM HOLDINGS INC (INFU). This can be considered as Fairly Valued.


What is the profitability of INFU stock?

INFUSYSTEM HOLDINGS INC (INFU) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for INFU stock?

The Price/Earnings (PE) ratio for INFUSYSTEM HOLDINGS INC (INFU) is 30 and the Price/Book (PB) ratio is 3.39.